MedTrace Logo

Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study

NCT06819527 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 323

Last updated 2026-01-29

No results posted yet for this study

Summary

This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.

Conditions

  • Chronic Kidney Disease(CKD)

Interventions

OTHER

Medication reconciliation service

Patients in the interventional group received medication reconciliation at admission and discharge in addition to continuous medication review during their admissions.

Sponsors & Collaborators

  • Jordan University of Science and Technology

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-08-30
Completion
2023-08-30

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06819527 on ClinicalTrials.gov